News
-
-
PRESS RELEASE
Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research initiates coverage on MaaT Pharma SACA with a BUY rating and EUR 17 price target. MaaT Pharma focuses on microbiome-based therapies for oncology, with high clinical impact and late-stage pipeline -
-
-
REGULATED PRESS RELEASE
Octobre 2025 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Communiqué mensuel sur le nombre total de droits de vote et d'actions de la société bioMérieux. Informations conformes aux réglementations en vigueur -
-
-
PRESS RELEASE
American Critical Minerals Announces Appointment of Dean Pekeski as Senior Advisor to the Company
American Critical Minerals Corp. appoints Dean Pekeski as Senior Advisor with extensive experience in potash exploration and development. Company focuses on Green River Potash and Lithium Project in Utah -
-